Urine test could reduce unnecessary prostate cancer biopsies

Published by  News Archive

On 10th Mar 2020

doctor and patient

Unnecessary prostate cancer biopsies could be reduced by 60 per cent thanks to new research from the University of East Anglia.

Researchers have developed new methods to identify biomarkers for prostate cancer by combining information from multiple parts of urine samples.

It is hoped that the breakthrough could help large numbers of men avoid an unnecessary initial biopsy.

Prostate cancer is the most common cancer in men in the UK. It usually develops slowly and the majority of cancers will not require treatment in a man’s lifetime.

The most commonly used tests for prostate cancer include blood tests, a physical examination known as a digital rectal examination (DRE), an MRI scan or a biopsy.

Lead author Shea Connell from UEA’s Norwich Medical School, said: “Prostate cancer is more commonly a disease men die with rather than from.

“Current practice assesses a patient’s disease using a PSA blood test, prostate biopsy and MRI. But up to 60 per cent of men with a raised PSA level are negative for prostate cancer on biopsy.

“So it is clear that there is a considerable need for additional, more accurate, tests.

Last year, the same team unveiled an experimental new test called ‘PUR’ (Prostate Urine Risk) which diagnoses aggressive prostate cancer and predicts whether patients will require treatment up to five years earlier than standard clinical methods.

The latest research combines information from two different components in urine which further improves its use for diagnosis.

Shea Connell said: “We wanted to see if other biological information from urine could be integrated together with clinical information to create a new predictive test with even greater potential.”

The team developed the ExoMeth test by studying urine samples collected from 197 patients. They used machine learning techniques to find which specific combination of biological markers could be useful for predicting the presence of prostate cancer.

ExoMeth takes a ‘holistic view’ of urine for biomarkers by considering much more than a single fraction of the urine. By integrating cell-free RNA, cellular methylation and clinical factors all together, the research team can now much more accurately discriminate the disease status of a patient without the need for an invasive biopsy.

It provides good evidence that multiple aspects of urine can be combined to determine a patient’s disease status.

Senior author Dr Daniel Brewer, from UEA’s Norwich Medical School, said: “It’s still very early days for this research, but if ExoMeth were validated in a future study with many more patients, we could see an approximate 60 per cent reduction in unnecessary biopsies in around five years.”

The research was led by UEA, in collaboration with the Norfolk and Norwich University Hospital, the Earlham Institute, University College Dublin, and the University of Toronto.

It was funded by Movember, the Masonic Charitable Foundation, the Bob Champion Cancer Trust, the King Family, the Andy Ripley Memorial Fund, the Hargrave Foundation, the US Prostate Cancer Foundation, the Science Foundation Ireland, the Royal Irish Academy and the Irish Cancer Society.

Dr Mark Buzza, global director of biomedical research programs at men’s health charity Movember said:  “Despite advances in recent years, prostate cancer remains very difficult to diagnose and treat. That’s why we’re so excited about the Exometh test. One of the major advantages of the test is that it could remove the need for 60 per cent of invasive biopsies.

“We are delighted to have supported this project under Movember’s Global Action Plan (GAP1) Biomarker project which fosters collaboration between researchers across the globe. Bringing researchers together to collaborate rather than compete for funding allows research findings to be fast-tracked.”

Development of a multivariable risk model integrating urinary cell DNA methylation & cell-free RNA data for the detection of significant prostate cancer’ is published in the journal The Prostate on March 10, 2020.

Study medicine at UEA

More world-leading research

Latest News

 
A forest fire in the Amazon rainforest.
27 Jan 2023

Human activity has degraded more than a third of remaining Amazon rainforest

The Amazon rainforest has been degraded by a much greater extent than scientists previously believed, according to a new study.

Read more >
 
A child learning to write the alphabet.
27 Jan 2023

Poor literacy linked to worse mental health worldwide, study shows

Read more >
 
A Vitamin D tablet being held up to the sun.
26 Jan 2023

80-year-old medical mystery that caused baby deaths solved

Researchers at the University of East Anglia have solved an 80-year-old medical mystery that causes kidney damage in children and can be fatal in babies.

Read more >
 
A loudspeaker at a protest.
23 Jan 2023

There may be more power in the hand of the worker than previously thought

Employers who disproportionately punish striking workers may be acting unlawfully, according to new research from the University of East Anglia.

Read more >
Are you searching for something?
 
A loudspeaker at a protest.
23 Jan 2023

There may be more power in the hand of the worker than previously thought

Employers who disproportionately punish striking workers may be acting unlawfully, according to new research from the University of East Anglia.

Read more >
 
Two bottles of hormones held in a gloved hand.
14 Jan 2023

HRT could ward off Alzheimer’s among at-risk women

Hormone Replacement Therapy (HRT) could help prevent Alzheimer’s Dementia among women at risk of developing the disease – according to University of East Anglia...

Read more >
 
A thermometer against a blue sky with blazing sun
12 Jan 2023

2022 sixth warmest year on record for global temperature

Globally 2022 was the sixth warmest year in a series stretching back to 1850, according to figures released today by the Met Office and University of East Anglia.

Read more >
 
Photo of Heidi Crisp
01 Jan 2023

HSC apprentice shortlisted for finalist in prestigious awards

Occupational therapist apprentice, Heidi Crisp has been shortlisted as one of three finalist  for Apprentice of the Year in the Norfolk Apprenticeship Awards. 

Read more >
 
Andy Cammidge
24 Jan 2023

New research grant will investigate novel organic materials

Prof Andy Cammidge (CHE) and colleagues have been awarded £800k from the Engineering and Physical Sciences Research Council to investigate the synthesis of new...

Read more >
 
James Bevan presenting at UEA. He is wearing glasses, a black jacket and grey trousers.
24 Jan 2023

UEA praised for 'outstanding' work on climate research

Sir James Bevan, Chief Executive of the Environment Agency, praised UEA’s outstanding work on climate research and highlighted the need to focus on climate...

Read more >
 
Steve Smith holding his award up with another person. Steve is wearing a grey suit.
11 Jan 2023

Nur-sing when you’re winning

National nursing award announced for retired university academic Steve Smith, aka the ‘Singing Lecturer’.

Read more >